RBRT19176, Milano, A071801, Metastatic Brain Disease, Radiation
Research Question:
How well does single fraction stereotactic radiosurgery works compared with fractionated
stereotactic radiosurgery in treating patients with cancer that has spread to the
brain from other parts of the body and has been removed by surgery?
Basic Study Information
Purpose:
This phase III trial studies how well single fraction stereotactic radiosurgery works
compared with fractionated stereotactic radiosurgery in treating patients with cancer
that has spread to the brain from other parts of the body and has been removed by
surgery. Single fraction stereotactic radiosurgery is a specialized radiation therapy
that delivers a single, high dose of radiation directly to the tumor and may cause
less damage to normal tissue. Fractionated stereotactic radiosurgery delivers multiple,
smaller doses of radiation therapy over time. This study may help doctors find out
if fractionated stereotactic radiosurgery is better or worse than the usual approach
with single fraction stereotactic radiosurgery.
Location: University of Rochester Medical Center
Study Reference #: RBRT19176
Lead Researcher (Principal Investigator)
Lead Researcher:
Michael Milano
Study Contact Information
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search